全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prevalence and Characterization of Pathogens Responsible for Enteric Fever and Assessment of Their Antibiotic Susceptibility Pattern in Bangladesh

DOI: 10.4236/pp.2024.159018, PP. 303-313

Keywords: Typhoid, Salmonella, Nalidixic Acid, Ciprofloxacin, Chloramphenicol, Cotrimoxazole

Full-Text   Cite this paper   Add to My Lib

Abstract:

In Bangladesh, Enteric fever is a persistent health issue throughout the year, occasionally reaching epidemic levels. The growing antibiotic resistance makes treatment increasingly challenging. Therefore, studying the antibiotic resistance patterns within the population is crucial to ensure a more effective treatment strategy. This study was designed to determine the prevalence, antimicrobial susceptibility profile, and factors associated with Salmonella spp. infections among clinically suspected Enteric fever patients in Bangladesh. This study also aimed to investigate whether there has been a re-emergence in the susceptibility of bacterial strains to conventional drugs. Data were collected from February 2024 to July 2024, from patients suspected Enteric fever (fever less than seven days duration) in a Private Diagnostic Center of Bangladesh. A total of 195 blood samples were cultured, where 53.85% came out positive, among which 79.05% Salmonella typhi and 20.95% Salmonella paratyphi A were found. Prevalence of Typhoid fever was observed high among the school-going age group (0 - 15 years) patients. Both these organisms were susceptible to ceftazidime, cefixime, ceftriaxone and cefepime but resistant to nalidixic acid, ciprofloxacin and levofloxacin. Nalidixic Acid is resistant to all S. paratyphi A and sensitive to few S. typhi. Ciprofloxacin and levofloxacin showed delayed response (36.14% and 22.72% sensitive to S. typhi and S. paratyphi A, respectively) and resistance (63.85% and 77.27% resistant to S. typhi and S. paratyphi A, respectively). In case of S. typhi, the resistance was found against ampicillin (32.53%), chloramphenicol (27.71%), cotrimoxazole (24.09%) and the resistance of S. paratyphi A found against ampicillin (4.54%), chloramphenicol (0%) and cotrimoxazole (0%). This study will provide clinicians with alternative drug options and facilitate the effective treatment of Enteric fever.

References

[1]  Adesegun, O., Adeyemi, O., Ehioghae, O., Rabor, D., Binuyo, T., Alafin, B., et al. (2020) Current Trends in the Epidemiology and Management of Enteric Fever in Africa: A Literature Review. Asian Pacific Journal of Tropical Medicine, 13, 204-213.
https://doi.org/10.4103/1995-7645.283515
[2]  World Health Organization (2018) Typhoid Fever.
https://www.who.int/news-room/fact-sheets/detail/typhoid
[3]  Stanaway, J.D., Reiner, R.C., Blacker, B.F., Goldberg, E.M., Khalil, I.A., Troeger, C.E., Andrews, J.R., Bhutta, Z.A., Crump, J.A., Im, J. and Marks, F. (2019) The Global Burden of Typhoid and Paratyphoid Fevers: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases, 19, 369-381.
[4]  Karkey, A., Arjyal, A., Anders, K.L., Boni, M.F., Dongol, S., Koirala, S., et al. (2010) The Burden and Characteristics of Enteric Fever at a Healthcare Facility in a Densely Populated Area of Kathmandu. PLOS ONE, 5, e13988.
https://doi.org/10.1371/journal.pone.0013988
[5]  Salman, Y., Asim, H., Hashmi, N., Islam, Z., Essar, M.Y. and Haque, M.A. (2022) Typhoid in Bangladesh: Challenges, Efforts, and Recommendations. Annals of Medicine & Surgery, 80, Article ID: 104261.
https://doi.org/10.1016/j.amsu.2022.104261
[6]  Senthilkumar, B., Senbagam, D. and Rajasekarapandian, M. (2012) An Epidemiological Surveillance of Asymptomatic Typhoid Carriers Associated in Respect to Socioeconomic Status in India. Journal of Public Health, 22, 297-301.
https://doi.org/10.1007/s10389-012-0545-4
[7]  Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., et al. (2023) Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11, Article No. 1946.
https://doi.org/10.3390/healthcare11131946
[8]  Cuypers, W.L., Jacobs, J., Wong, V., Klemm, E.J., Deborggraeve, S. and Van Puyvelde, S. (2018) Fluoroquinolone Resistance in Salmonella: Insights by Whole-Genome Sequencing. Microbial Genomics, 4, e000195.
https://doi.org/10.1099/mgen.0.000195
[9]  Espunyes, J., Illera, L., Dias-Alves, A., Lobato, L., Ribas, M.P., Manzanares, A., et al. (2022) Eurasian Griffon Vultures Carry Widespread Antimicrobial Resistant Salmonella and Campylobacter of Public Health Concern. Science of the Total Environment, 844, Article ID: 157189.
https://doi.org/10.1016/j.scitotenv.2022.157189
[10]  Talukder, H., Roky, S.A., Debnath, K., Sharma, B., Ahmed, J. and Roy, S. (2023) Prevalence and Antimicrobial Resistance Profile of Salmonella Isolated from Human, Animal and Environment Samples in South Asia: A 10-Year Meta-Analysis. Journal of Epidemiology and Global Health, 13, 637-652.
https://doi.org/10.1007/s44197-023-00160-x
[11]  Qian, H., Cheng, S., Liu, G., Tan, Z., Dong, C., Bao, J., et al. (2020) Discovery of Seven Novel Mutations of Gyrb, Parc and Pare in Salmonella typhi and paratyphi Strains from Jiangsu Province of China. Scientific Reports, 10, Article No. 7359.
https://doi.org/10.1038/s41598-020-64346-0
[12]  Petersiel, N., Shresta, S., Tamrakar, R., Koju, R., Madhup, S., Shresta, A., et al. (2018) The Epidemiology of Typhoid Fever in the Dhulikhel Area, Nepal: A Prospective Cohort Study. PLOS ONE, 13, e0204479.
https://doi.org/10.1371/journal.pone.0204479
[13]  Kunwar, D., Bhatta, S., Chaudhary, R. and Rijal, K.R. (2018) Antibiotic Susceptibility Pattern of Nalidixic Acid Resistant Salmonella Isolates in Shree Birendra Hospital Chhauni. Tribhuvan University Journal of Microbiology, 4, 11-14.
https://doi.org/10.3126/tujm.v4i0.21669
[14]  Rowe, B., Ward, L.R. and Threlfall, E.J. (1997) Multidrug-Resistant Salmonella typhi: A Worldwide Epidemic. Clinical Infectious Diseases, 24, S106-S109.
https://doi.org/10.1093/clinids/24.supplement_1.s106
[15]  Ventola, C.L. (2015) The Antibiotic Resistance Crisis: Part 2: Management Strategies and New Agents. Pharmacy and Therapeutics, 40, 344-352.
[16]  Weyant, C., Hooda, Y., Munira, S.J., Lo, N.C., Ryckman, T., Tanmoy, A.M., et al. (2024) Cost-Effectiveness and Public Health Impact of Typhoid Conjugate Vaccine Introduction Strategies in Bangladesh. Vaccine, 42, 2867-2876.
https://doi.org/10.1016/j.vaccine.2024.03.035
[17]  Isenberg, H.D. (2004) Clinical Microbiology Procedures Handbook. ASM Press.
[18]  PA, W. (2011) Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement. CLSI Document, 31, 100.
[19]  Maharjan, A., Dhungel, B., Bastola, A., Thapa Shrestha, U., Adhikari, N., Banjara, M.R., et al. (2021) Antimicrobial Susceptibility Pattern of Salmonella Spp. Isolated from Enteric Fever Patients in Nepal. Infectious Disease Reports, 13, 388-400.
https://doi.org/10.3390/idr13020037
[20]  Antillón, M., Warren, J.L., Crawford, F.W., Weinberger, D.M., Kürüm, E., Pak, G.D., et al. (2017) The Burden of Typhoid Fever in Low-and Middle-Income Countries: A Meta-Regression Approach. PLOS Neglected Tropical Diseases, 11, e0005376.
https://doi.org/10.1371/journal.pntd.0005376
[21]  Adhikari, D., Acharya, D., Shrestha, P. and Amatya, R. (2012) Ciprofloxacin Susceptibility of Salmonella Enteric Serovar typhi and paratyphi a from Blood Samples of Suspected Enteric Fever Patients. International Journal of Infection and Microbiology, 1, 9-13.
https://doi.org/10.3126/ijim.v1i1.6938
[22]  Levinson, W. (2004) Medical Microbiology and Immunology. 8th Edition, Lang Medical Books/McGraw-Hill.
[23]  Britto, C.D., Wong, V.K., Dougan, G. and Pollard, A.J. (2018) A Systematic Review of Antimicrobial Resistance in Salmonella enterica Serovar typhi, the Etiological Agent of Typhoid. PLOS Neglected Tropical Diseases, 12, e0006779.
https://doi.org/10.1371/journal.pntd.0006779
[24]  Parry, C.M., Hoa, N.T.T., Diep, T.S., Wain, J., Chinh, N.T., Vinh, H., et al. (1999) Value of a Single-Tube Widal Test in Diagnosis of Typhoid Fever in Vietnam. Journal of Clinical Microbiology, 37, 2882-2886.
https://doi.org/10.1128/jcm.37.9.2882-2886.1999
[25]  Girard, M.P., Steele, D., Chaignat, C. and Kieny, M.P. (2006) A Review of Vaccine Research and Development: Human Enteric Infections. Vaccine, 24, 2732-2750.
https://doi.org/10.1016/j.vaccine.2005.10.014
[26]  Khanal, P.R., Satyal, D., Bhetwal, A., Maharjan, A., Shakya, S., Tandukar, S., et al. (2017) Renaissance of Conventional First-Line Antibiotics in Salmonella enterica Clinical Isolates: Assessment of Mics for Therapeutic Antimicrobials in Enteric Fever Cases from Nepal. BioMed Research International, 2017, Article ID: 2868143.
https://doi.org/10.1155/2017/2868143
[27]  Akter, L. (2012) Present Status and Antibiotic Sensitivity Pattern of Salmonella typhi and S. paratyphi in Different Age Group Hospitalized Patients in Dhaka City, Bangladesh. IOSR Journal of Pharmacy and Biological Sciences, 4, 27-30.
https://doi.org/10.9790/3008-0432730
[28]  Gupta, V., Kaur, J. and Kaistha, N. (2009) Re-Emerging Chloramphenicol Sensitivity and Emerging Low Level Ciprofloxacin Resistance among Salmonella enterica Serotype Typhi Isolates in North India. Tropical Doctor, 39, 28-30.
https://doi.org/10.1258/td.2008.070452
[29]  Sibanda, T. and Okoh, A.I. (2007) The Challenges of Overcoming Antibiotic Resistance: Plant Extracts as Potential Sources of Antimicrobial and Resistance Modifying Agents. African Journal of Biotechnology, 6, 2886-2896.
[30]  World Health Organization (WHO) (2002) Antimicrobial Resistance. Fact Sheet No. 194.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133